Literature DB >> 31531

3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC.

A Groppetti, M Parenti, C L Galli, A Bugatti, F Cattabeni, A M Di Giulio, G Racagni.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 31531     DOI: 10.1016/0024-3205(78)90105-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  7 in total

1.  Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists.

Authors:  C A Altar; W C Boyar; A Wasley; S C Gerhardt; J M Liebman; P L Wood
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

Review 2.  Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine.

Authors:  M F Egan; S Chrapusta; F Karoum; B K Lipska; R J Wyatt
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 3.  Mechanisms of action of atypical antipsychotic drugs: a critical analysis.

Authors:  B J Kinon; J A Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

4.  3-Methoxytyramine: its suitability as an indicator of synaptic dopamine release.

Authors:  P C Waldmeier; J Lauber; W Blum; W J Richter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-01       Impact factor: 3.000

5.  Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.

Authors:  F Karoum; M F Egan
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

6.  3-Methoxytyramine and normetanephrine as indicators of dopamine and noradrenaline release in mouse brain in vivo.

Authors:  W Kehr
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

7.  3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.

Authors:  C F Saller; A I Salama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.